Patients with chronic liver disease are at greater risk of complications and mortality following endoscopic retrograde cholangiopancreatography.

Galzin (zinc acetate capsules) is now available for maintenance treatment of patients with Wilson disease who have been initially treated with a chelating agent.

Gastroesophageal symptoms significantly impact methotrexate dosages and disease activity among patients with RA.

Between 2013 and 2023, there was no change in the prevalence of diabetes among US adults, but glycemic control worsened.

For patients with T2D, GLP-1 RA is associated with a reduced risk for developing hematologic cancers compared with insulin and metformin.

Twelve percent of the US adult population borrowed $74 billion last year to help pay medical costs for themselves or a family member.

People with disabilities are more likely to report negative experiences with the cultural responsiveness of health care providers.

Findings were announced from a phase 3 trial evaluating guselkumab subcutaneous induction therapy in patients with moderately to severely active ulcerative colitis.

Among individuals with relapsing-remitting MS, intermittent calorie restriction and ketogenic diets reduce metabolomic age.

A retrospective population-based study showed that severe obesity and bariatric surgery independently increased the risk of inflammatory bowel disease.

The makers of weight-loss drugs Wegovy and Zepbound are cutting prices to make the medications more affordable for people without insurance.

One-third of children with metabolic dysfunction-associated steatotic liver disease receiving standard of care showed improvement after 2 years.